TNF and inflammatory bowel disease: A recent meta-analysis concluded that pre-operative vedolizumab treatment in patients with IBD did not appear to be associated with an increased risk of post-operative infectious or overall post-operative complications compared with either pre-operative anti-TNFα therapy or non-biologic therapy [22].